FIM
ENTL

Freedom Investment Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Freedom Investment Management’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-44,769
Closed -$1.09M – 1255
2017
Q4 		$1.09M Buy
44,769
+840
+2% +$16.1K 0.06% 336
2017
Q3 		$811K Buy
43,929
+7,311
+20% +$127K 0.04% 408
2017
Q2 		$606K Buy
36,618
+3,143
+9% +$43.7K 0.03% 489
2017
Q1 		$462K Buy
33,475
+6,223
+23% +$99.9K 0.03% 564
2016
Q4 		$517K Buy
27,252
+1,094
+4% +$21K 0.03% 472
2016
Q3 		$580K Sell
26,158
-210
-0.8% -$3.94K 0.04% 412
2016
Q2 		$482K Buy
26,368
+9,912
+60% +$171K 0.03% 426
2016
Q1 		$299K Buy
+16,456
New +$266K 0.02% 556

Freedom Investment Management's ENTL Position: Q1 2018 in Review

Freedom Investment Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 44,769 shares — an estimated $1.09M sold.

Freedom Investment Management first reported a position in ENTL in Q1 2016 and held it in 8 quarters. The position peaked at $1.09M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Freedom Investment Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Freedom Investment Management sold 44,769 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.09M.
  • Freedom Investment Management first reported a position in Entellus Medical, Inc. Common Stock in Q1 2016 and held it in 8 quarters.
  • Freedom Investment Management's Entellus Medical, Inc. Common Stock position peaked at $1.09M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Freedom Investment Management's 13F filing for Q1 2018, filed 6 Apr 2018.